Circulating CXCR6+PD-1+ CD8 T cells are associated with liver inflammation and disease severity in hepatitis flares
Souleiman R, Chou Y, Yang T, Freyer E, Carpentier A, Dey S, Niehaus C, Wintersteller H, Falk C, Maasoumy B, Ravens S, Wedemeyer H, Kraft A, Heinrich B, Cornberg M
Published in
Clinical and Molecular Hepatology, Page 10.3350/cmh.2026.0318
Abstract
BACKGROUND/AIMS: Marked hepatitis flares, defined in this study as alanine aminotransferase (ALT) elevations exceeding five times the upper limit of normal, occur in acute and chronic liver diseases and may be associated with severe liver injury. However, the circulating immune profiles associated with the extent of liver injury remain incompletely characterized. We aimed to characterize circulating CD8 T cell phenotypes and soluble immune mediators during hepatitis flares across different etiologies. METHODS: In a retrospective cross-sectional analysis, soluble immune mediators and circulating CD8 T cell phenotypes were analyzed in 71 patients with hepatitis flares using Luminex assays and spectral flow cytometry. Exploratory functional experiments included in vitro PBMC stimulation and co-culture of sorted CD8 T cell subsets with Huh7 hepatoma cells. A public HBV single-cell RNA-sequencing dataset was reanalyzed to contextualize circulating and intrahepatic CD8 T cell states. RESULTS: Circulating CXCR6+PD-1+ CD8 T cell frequencies were associated with biochemical markers of liver injury and dysfunction. HLA-DR expression within this subset was associated with the hepatocyte injury index, bilirubin levels, and plasma CXCL10 (IP-10) concentrations. Activation-marker and granzyme expression differed across flare etiologies, and CXCR6+PD-1+ CD8 T cells retained inducible effector responses following cytokine stimulation. Reanalysis of a public HBV scRNA-seq dataset identified a liver-enriched CXCR6/PDCD1/HLA-DRAhi GZMKhi CD8 T cell state. CONCLUSION: Circulating CXCR6+PD-1+ CD8 T cells represent an activation-associated population that correlates with biochemical liver injury during hepatitis flares and retains inducible effector capacity. Whether these cells contribute to or reflect ongoing liver inflammation remains to be determined.
Open in PubMed